Clinical Lymphology and Lymphedema
Korean Society of Lymphology and Lymphedema
REVIEW ARTICLE

림프부종 환자의 생활 관리

류은정1,*
Eunjung Ryu1,*
1중앙대학교 적십자간호대학 간호학교실
1Department of Nursing, Chung-Ang University Red Cross College of Nursing, Seoul, Korea
*Corresponding Author : Eunjung Ryu, RN, PhD, Department of Nursing, Chung-Ang University Red Cross College of Nursing, 84 Heukuk-ro, Dongjak-gu, Seoul 06911, Korea, Tel: +82-2-820-5681, Fax: +82-2-824-7961, E-mail: go2ryu@cau.ac.kr

ⓒ Copyright 2016 Korean Society of Lymphology and Lymphedema. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Apr 18, 2016; Accepted: Apr 26, 2016

Published Online: Apr 30, 2016

Abatract

Lymphedema is the accumulation of protein-rich fluid in tissues with inadequate lymph drainage and also a chronic, progressive condition without a cure. The purpose of this review is to provide information to assist the person with or at risk for lymphedema to make the best possible and most informed choices about risk-reduction practice for healthy lifestyle. This review differentiates people with a confirmed diagnosis of lymphedema from people at risk of lymphedema, individuals who have not displayed the signs and symptoms of lymphedema. Lymphedema is chronic and disfiguring. Despite the lack of evidence-based research on lymphedema, the Korean Society of Lymphedema clinical guideline is based on sound physiologic and clinical principles. In clinical practice, health professionals should inform both people with a confirmed diagnosis of lymphedema and at risk of lymphedema about their risk for lymphedema, guidelines to reduce that risk, and the physiologic rationale for the guidelines.

Keywords: Cancer; Lymphedema; Guideline